Teaching Responsibility
LJMU Schools involved in Delivery:
Pharmacy & Biomolecular Sciences
Learning Methods
Lecture
Workshop
Module Offerings
5001MPHARM-SEP-CTY
Aims
To report on the formulation, manufacture and testing of a medicine using a range of scientific data and information, and discuss their clinical significance
Learning Outcomes
1.
Describe the methods and results for formulating, manufacturing and testing a medicine
2.
Analyse a range of scientific data on the formulation, manufacture and testing of a medicine
3.
Explain the effect of variations in scientific data on the quality and safety of medicine use in practice
4.
Demonstrate effective communication, analytical and critical–thinking skills
Module Content
Outline Syllabus:
The syllabus for level 4 MPharm can be viewed in the 5000MPHARM module
The syllabus for level 4 MPharm can be viewed in the 5000MPHARM module
Module Overview:
This module is solely for assessment and this assessment focuses on student research skills in year 2.
This module is solely for assessment and this assessment focuses on student research skills in year 2.
Additional Information:
This module is for summative assessment only. All learning, formative assessment and feedback for this assessment are included in the content module 5000MPHARM, and build on learning from 4000MPHARM.
To ensure the programme aligns to the GPhC commitment to patient safety, this assessment will include a check as to whether a pharmacy student is demonstrating they are able to practise safely. To achieve the assessment pass mark, students must be able to demonstrate their ability to apply the principles and concepts of safe, person-centred practice in both clinical and non-clinical environments and scenarios. The marking rubric for coursework assessments includes the option to deduct an unlimited number of marks for patient safety concerns, which will be dependent on the severity of potential harm their actions or decision may cause, and/or repetition of the actions. For incidents of severe potential patient harm the mark may be reduced to zero, regardless of its merits elsewhere, and the assessment would be recorded as a fail.
Students must be successful in the module to progress to the next level of study.
No compensation, no trailing.
This module is for summative assessment only. All learning, formative assessment and feedback for this assessment are included in the content module 5000MPHARM, and build on learning from 4000MPHARM.
To ensure the programme aligns to the GPhC commitment to patient safety, this assessment will include a check as to whether a pharmacy student is demonstrating they are able to practise safely. To achieve the assessment pass mark, students must be able to demonstrate their ability to apply the principles and concepts of safe, person-centred practice in both clinical and non-clinical environments and scenarios. The marking rubric for coursework assessments includes the option to deduct an unlimited number of marks for patient safety concerns, which will be dependent on the severity of potential harm their actions or decision may cause, and/or repetition of the actions. For incidents of severe potential patient harm the mark may be reduced to zero, regardless of its merits elsewhere, and the assessment would be recorded as a fail.
Students must be successful in the module to progress to the next level of study.
No compensation, no trailing.